Sunshine Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUNSHINE, and what generic and branded alternatives to SUNSHINE drugs are available?
SUNSHINE has twenty-eight approved drugs.
There are three tentative approvals on SUNSHINE drugs.
Drugs and US Patents for Sunshine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sunshine | AMLODIPINE BESYLATE | amlodipine besylate | TABLET;ORAL | 206524-001 | May 4, 2018 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Sunshine | TADALAFIL | tadalafil | TABLET;ORAL | 211335-003 | Mar 26, 2019 | AB1 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Sunshine | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 211865-001 | Mar 23, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Sunshine | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 212739-001 | Mar 4, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Sunshine | AZITHROMYCIN | azithromycin | TABLET;ORAL | 209045-001 | Dec 7, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Sunshine | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 211865-002 | Mar 23, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Sunshine | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 208999-001 | Oct 12, 2018 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.